Literature DB >> 4279816

The relief of bone pain in primary biliary cirrhosis with calcium infusions.

A B Ajdukiewicz, J E Agnew, P D Byers, M R Wills, S Sherlock.   

Abstract

Intravenous calcium infusions produced subjective relief of bone pain in 14 patients with primary biliary cirrhosis. The bone pain had developed despite long-term parenteral vitamin D therapy. The pain returned after two to three months, but a subsequent course of infusions again brought relief. Before treatment satisfactory iliac crest bone biopsies were obtained in 11 of the patients and were normal in seven; two patients had biopsies indicating osteomalacia and two osteoporosis. After treatment a repeat biopsy in one of the patients with osteomalacia showed marked reduction in osteoid. The infusion treatment produced no change in plasma calcium concentration, serum phosphate, or serum alkaline phosphatase. Absorption of oral calcium was also unchanged.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4279816      PMCID: PMC1412984          DOI: 10.1136/gut.15.10.788

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  10 in total

1.  [The phosphocalcium syndrome of cirrhosis].

Authors:  A LICHTWITZ; M CACHIN; D HIOCO; M TUTIN
Journal:  Sem Hop       Date:  1959 Aug 18-28

2.  Malabsorption and bone disease in prolonged obstructive jaundice.

Authors:  M ATKINSON; B E NORDIN; S SHERLOCK
Journal:  Q J Med       Date:  1956-07

3.  A calcium-infusion test. I. Urinary excretion data for recognition of osteomalacia.

Authors:  B E NORDIN; R FRASER
Journal:  Lancet       Date:  1956-06-02       Impact factor: 79.321

4.  The presentation and diagnosis of 100 patients with primary biliary cirrhosis.

Authors:  S Sherlock; P J Scheuer
Journal:  N Engl J Med       Date:  1973-09-27       Impact factor: 91.245

5.  The regulation of vitamin D metabolism.

Authors:  L Galante; K W Colston; I M Evans; P G Byfield; E W Matthews; I MacIntyre
Journal:  Nature       Date:  1973-08-17       Impact factor: 49.962

6.  Intestinal absorption of calcium.

Authors:  M R Wills
Journal:  Lancet       Date:  1973-04-14       Impact factor: 79.321

7.  Calcium infusion in painful Paget's disease of bone.

Authors:  R Sekel
Journal:  Lancet       Date:  1973-02-17       Impact factor: 79.321

8.  Bone disease and calcium absorption in primary biliary cirrhosis with special reference to vitamin-D therapy.

Authors:  A K Kehayoglou; C D Holdsworth; J E Agnew; M J Whelton; S Sherlock
Journal:  Lancet       Date:  1968-04-06       Impact factor: 79.321

9.  Comparison of three isotopic methods for the study of calcium absorption.

Authors:  J E Agnew; A K Kehayoglou; C D Holdsworth
Journal:  Gut       Date:  1969-07       Impact factor: 23.059

10.  The treatment of osteoporosis with calcium infusions. Clinical studies.

Authors:  C Y Pak; R Evens; J Jowsey; C S Delea; F C Bartter
Journal:  Am J Med       Date:  1969-07       Impact factor: 4.965

  10 in total
  5 in total

Review 1.  Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease.

Authors:  J E Compston
Journal:  Gut       Date:  1986-09       Impact factor: 23.059

2.  Vitamin D metabolism in acute and chronic cholestasis.

Authors:  R T Jung; M Davie; P Siklos; T M Chalmers; J O Hunter; D E Lawson
Journal:  Gut       Date:  1979-10       Impact factor: 23.059

3.  Effect of oral 1,25 dihydroxycholecalciferol on calcium and phosphate malabsorption in primary biliary cirrhosis.

Authors:  K Farrington; O Epstein; Z Varghese; S P Newman; J F Moorhead; S Sherlock
Journal:  Gut       Date:  1979-07       Impact factor: 23.059

4.  Parenteral 1,25-dihydroxycholecalciferol in hepatic osteomalacia.

Authors:  R G Long; Z Varghese; E A Meinhard; R K Skinner; M R Wills; S Sherlock
Journal:  Br Med J       Date:  1978-01-14

5.  Vitamin D deficiency, osteomalacia, and primary biliary cirrhosis. Response to orally administered vitamin D3.

Authors:  M Davies; E B Mawer; H J Klass; G A Lumb; J L Berry; T W Warnes
Journal:  Dig Dis Sci       Date:  1983-02       Impact factor: 3.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.